金黄色葡萄球菌菌血症临床亚型的可重复性识别
该研究在三个观察性队列(英国、荷兰、美国)中,使用潜在类别分析从常规临床数据中识别金黄色葡萄球菌菌血症(SAB)的临床亚型。结果在每个队列中均重复识别出5种不同亚型,且各亚型间90天死亡率和持续性菌血症存在差异。这些可重复的临床亚型为理解SAB的异质性提供了框架。
要点
- 在三个地理和遗传背景不同的队列中均重复识别出5种SAB临床亚型。
- 亚型A的90天死亡率最高,亚型C和E的持续性菌血症风险最高。
- 细菌基因型在队列间差异显著,但各亚型内基因型分布无差异。
核心结论
- 在包含不同细菌遗传谱系及高MRSA/USA300流行率的观察性队列中,可重复识别出5种SAB临床亚型,为合理化SAB内在异质性提供框架。
研究设计与样本
- 研究分析了三个成人SAB观察性队列:英国回顾性Edinburgh队列2(n=463)、荷兰前瞻性IDISA研究(n=490)和美国前瞻性SABG-PCS研究(n=755)。
- 使用潜在类别分析从常规可获得的临床数据中识别亚型。
主要发现
- SABG-PCS队列患者合并症更多,MRSA菌血症比例为40.2%(303/755),USA300克隆感染比例为14.7%(111/755)。
- 每个队列均识别出5种亚型:(1)高龄和心血管代谢多病;(2)医院获得性和静脉导管入口;(3)社区获得性和转移性感染;(4)慢性肾病;(5)年轻、注射吸毒和转移性感染。
- 90天死亡率在亚型A最高,持续性菌血症在亚型C和E最高。
- Edinburgh 2和SABG-PCS队列间细菌基因型差异显著,但各队列内亚型间基因型无差异。
临床怎么用
- 这些可重复的临床亚型有助于对SAB患者进行风险分层,识别高死亡风险(亚型A)和高持续性菌血症风险(亚型C和E)的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinical heterogeneity in Staphylococcus aureus bacteremia (SAB) complicates clinical management and research. We have previously identified 5 clinically distinct subphenotypes of SAB associated with differences in outcomes and response to adjunctive rifampicin. Here, we aimed to identify these subphenotypes in geographically diverse observational cohorts, including a higher prevalence of methicillin-resistant S. aureus (MRSA) bacteremia and the USA300 clone. METHODS: We studied 3 cohorts of adults with SAB from observational studies: a UK retrospective study (Edinburgh cohort 2; n = 463); a Dutch prospective study (IDISA [Improved Diagnostic Strategies in Staphylococcus aureus bacteremia study]; n = 490); and a prospective US study (SABG-PCS [Staphylococcus aureus Bacteremia Group Prospective Cohort Study]; n = 755). Subphenotypes were identified from routinely available clinical data using latent class analysis. RESULTS: Patients from the SABG-PCS cohort had greater multimorbidity and more MRSA bacteremia (40.2% [303 of 755]), including infection with the USA300 clone (14.7% [111 of 755]). Five distinct subphenotypes were identified in each cohort: (1) older age and cardiometabolic multimorbidity; (2) nosocomial acquisition and intravenous catheter portal of entry; (3) community acquisition and metastatic infection; (4) chronic kidney disease; and (5) younger age, injection drug use, and metastatic infection. Bacterial genotypes varied substantially between the Edinburgh 2 and SABG-PCS cohorts but did not differ between subphenotypes within each cohort. 90-day mortality was highest in subphenotype A, and persistent bacteremia in subphenotypes C and E. CONCLUSIONS: We have reproducibly identified 5 clinical subphenotypes of SAB in observational cohorts including diverse bacterial genetic lineages and a cohort with a high prevalence of MRSA and USA300 bacteremia. These robustly reproducible clinical subphenotypes provide a framework to rationalize the heterogeneity intrinsic to SAB.
引用
- Swets MC, Bakk Z, Westgeest AC, et al. Reproducible Identification of Staphylococcus aureus Bacteremia Clinical Subphenotypes. Clin Infect Dis. 2026. PMID: 41307923. doi:10.1093/cid/ciaf655
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。